Start your intake What Clinical Trials Actually Show About GLP-1 Efficacy The STEP trials (semaglutide) and SURPASS trials (tirzepatide) provide the largest clinical datasets
Semaglutide and liraglutide also reduce release of glucagon, a hormone that increases blood sugar levels, as well as inhibit gluconeogenesis, a process of converting glycogen in the liver to glucose in the blood
The oncogenic role of ferroptosis While ferroptosis is primarily known for its tumor-suppressive function, it can also paradoxically promote tumor progression through its effects on immune cells and the TME
Activation of trypsin induces the leakage of lysosomes and the release of cathepsin B into the cytoplasm, which activates the cell death pathway and finally causes pancreatic injury mainly in the forms of cellular apoptosis and necrosis 21
Evaluation of long-term treatment effect in a type 1 diabetes intervention trial: differences after stimulation with glucagon or a mixed meal
Optimized Treatment Outcomes : By harnessing the advantages of both delivery routes, our special combination route maximizes treatment outcomes for patients with Graves disease
